Local
Creative Biolabs Highlights Critical Gaps in Complement Drug Screening
Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.
Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.
Source: Union
Creative Biolabs highlights how C1q binding, C3b deposition, and hemolytic inhibition assays address different questions in complement drug screening, helping researchers interpret preclinical results.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Union



